Affordability Check
How to afford KESIMPTA
Generic name: ofatumumab
Pick how you're covered. We'll show you the cheapest legitimate way to get KESIMPTA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About KESIMPTA and its cost
What is this medication? Kesimpta is a prescription medication used to treat adults with relapsing forms of multiple sclerosis, also known as MS. This includes individuals diagnosed with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The active ingredient, ofatumumab, is a monoclonal antibody that targets specific B cells in the immune system. By binding to the CD20 protein on these cells, the medication helps reduce the immune-mediated attacks on the central nervous system that lead to nerve damage and physical symptoms.
The medicine is designed for self-administration via a subcutaneous injection once a month after an initial loading dose period. Its primary goal is to lower the frequency of relapses, slow the accumulation of physical disability, and minimize the development of new brain lesions. Because it suppresses a portion of the immune system, it is important for patients to discuss potential side effects and their vaccination history with a healthcare provider before starting the treatment regimen.
KESIMPTA is made by a pharmaceutical manufacturer. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford KESIMPTA?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for KESIMPTA?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But the manufacturer has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover KESIMPTA?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Multiple Sclerosis?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about KESIMPTA
Full KESIMPTA drug page
FDA label, prior authorization rules, full indications list
More options for Multiple Sclerosis
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3